Th1/Th2 cells in patients with multiple myeloma
- PMID: 14965867
- DOI: 10.1080/10245330310001652437
Th1/Th2 cells in patients with multiple myeloma
Abstract
Multiple myeloma (MM) is a lymphoproliferative disorder that is characterized by a proliferation of clonal B cells in various stages of maturation that then infiltrate the bone marrow. MM has been reported to accompany various T cell abnormalities including quantitative and functional defects of CD4+ and CD8+ T cells. Recently, immunotherapy such as dendritic cell therapy, vaccination therapy, and anti-tumor antibody therapy, has been attempted in patients with MM. To develop more effective immunotherapy for patients with MM, further studies are required to identify the immunological abnormalities, especially in T cells, associated with MM. The T helper 1 (Th1) and T helper 2 (Th2) cells are characterized by distinct cytokine production patterns. The Th1 cells produce interferon gamma and interleukin-2 (IL-2), and are involved in cell-mediated immunity. The Th2 cells produce IL-4 and promote humoral immunity by stimulating antibody production, particularly IgE responses. Furthermore, Th1 and Th2 cells have been found to cross-regulate each other's development. The Th1/Th2 combination has an important role in immune response to many disorders including infection, autoimmune diseases, and malignancies. In this review, we report a Th1/Th2 imbalance in cases of MM, and discuss the relationship between T cell abnormalities and the pathology of MM.
Similar articles
-
T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.Pediatrics. 2006 May;117(5):e878-86. doi: 10.1542/peds.2005-2119. Epub 2006 Apr 17. Pediatrics. 2006. PMID: 16618789
-
[A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].Rinsho Byori. 1998 Sep;46(9):915-21. Rinsho Byori. 1998. PMID: 9800477 Review. Japanese.
-
Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.Anticancer Res. 2006 Mar-Apr;26(2A):1113-34. Anticancer Res. 2006. PMID: 16619514 Review.
-
Dehydroepiandrosterone modulates T-cell response after major abdominal surgery.J Surg Res. 2014 Jun 1;189(1):117-25. doi: 10.1016/j.jss.2014.02.002. Epub 2014 Feb 12. J Surg Res. 2014. PMID: 24650456
-
Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.J Leukoc Biol. 2005 Sep;78(3):656-64. doi: 10.1189/jlb.1104631. Epub 2005 Jun 16. J Leukoc Biol. 2005. PMID: 15961574
Cited by
-
Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine.Molecules. 2024 May 17;29(10):2374. doi: 10.3390/molecules29102374. Molecules. 2024. PMID: 38792234 Free PMC article. Review.
-
TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.Front Immunol. 2024 Feb 26;15:1356833. doi: 10.3389/fimmu.2024.1356833. eCollection 2024. Front Immunol. 2024. PMID: 38629068 Free PMC article.
-
New insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines.Front Microbiol. 2022 Nov 28;13:1073922. doi: 10.3389/fmicb.2022.1073922. eCollection 2022. Front Microbiol. 2022. PMID: 36519164 Free PMC article. Review.
-
Natural Products as Anticancer Agents: Current Status and Future Perspectives.Molecules. 2022 Nov 30;27(23):8367. doi: 10.3390/molecules27238367. Molecules. 2022. PMID: 36500466 Free PMC article. Review.
-
PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.Ann Transl Med. 2022 Feb;10(4):227. doi: 10.21037/atm-22-198. Ann Transl Med. 2022. PMID: 35280367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials